Status:
COMPLETED
Functional Respiratory Imaging After Neostigmine or Sugammadex
Lead Sponsor:
Onze Lieve Vrouw Hospital
Collaborating Sponsors:
Universiteit Antwerpen
MSD Belgium BVBA
Conditions:
Respiratory-Gated Imaging Techniques
Eligibility:
MALE
3-6 years
Phase:
PHASE4
Brief Summary
The use of neuromuscular blocking agents (NMBAs) is still associated with postoperative pulmonary complications. The investigators rely on acceleromyography (AMG) of a peripheral nerve/muscle to asses...
Detailed Description
This study is designed to assess the effect of sugammadex, neostigmine/glycopyrrolate and spontaneous reversal of a moderate rocuronium-induced neuromuscular blockade on regional lung ventilation. Thi...
Eligibility Criteria
Inclusion
- male Sprague-Dawley rats
Exclusion
- N/A
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT02284412
Start Date
December 1 2014
End Date
April 1 2015
Last Update
April 21 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
OLV Hospital
Aalst, Belgium, 9300